Running Stocks: Goldcorp (NYSE:GG), CNB Financial Corp. (NASDAQ:CCNE), Cliffs Natural Resources (NYSE:CLF), Catalyst Pharmaceuticals (NASDAQ:CPRX)

Monsanto Company (NYSE:MON) shares fell -0.81% in last trading session and ended the day at $89.17. MON Gross Margin is 53.50% and its has a return on assets of 8.30%. Monsanto Company (NYSE:MON) quarterly performance is -4.23%.

Monsanto Company (NYSE:MON) released its 2015 Sustainability Report. Since announcing some initial sustainability commitments in 2008, the company has advanced its principle of pursuing a broad range of sustainable agricultural solutions to help nourish a growing world.

Goldcorp Inc. (NYSE:GG) caters to the Basic Materials space. It has a net profit margin of -95.00% and weekly performance is 2.96%. On the last day of trading company shares ended up at $16.02. Goldcorp Inc. (NYSE:GG) distance from 50-day simple moving average (SMA50) is 20.90%.

Goldcorp Inc. (NYSE:GG) announced that it has reduced its annual dividend to $0.08 per share effective April 1, 2016 and amended its dividend payment schedule such that future dividends will be paid quarterly commencing in June 2016.

On 15 March, CNB Financial Corp. (NASDAQ:CCNE) shares fell -0.22% and was closed at $17.96. CCNE EPS growth in last 5 year was 7.80%. CNB Financial Corp. (NASDAQ:CCNE) year to date (YTD) performance is -0.39%.

CNB Financial Corp (NASDAQ:CCNE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a report issued on Tuesday, Market Beat Ratings reports.

Cliffs Natural Resources Inc. (NYSE:CLF) shares fell -12.18% in last trading session and ended the day at $2.38. CLF Gross Margin is 11.70% and its has a return on assets of -32.40%. Cliffs Natural Resources Inc. (NYSE:CLF) quarterly performance is 13.88%.

Cliffs Natural Resources Inc. (NYSE:CLF) issued the statement regarding the recently filed lawsuit by certain Plaintiff Noteholders: Cliffs typically does not comment on litigation matters. However, the Company felt compelled to state its belief that this lawsuit over the note exchanges in January 2016 is entirely without merit. Cliffs fully intends to defend vigorously against the claims

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) caters to the Healthcare space. Its weekly performance is -11.11%. On the last day of trading company shares ended up at $1.12. Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) distance from 50-day simple moving average (SMA50) is -0.16%.

On 15 March, Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) reported financial results for the fourth quarter and the year-ended December 31, 2015. For the year ended December 31, 2015, Catalyst reported a GAAP net loss of $20,232,958, or $0.25 per basic and diluted share, compared to a GAAP net loss of $15,509,061, or $0.24 per basic and diluted share, for the 2014 fiscal year.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *